Test shows efficacy in detecting neuropathy in diabetes

05/6/2013 | Healio

A study presented at the American Association of Clinical Endocrinologists annual meeting found diabetes patients with neuropathy showed worse electrochemical skin conductance, as measured by the FDA-approved Sudoscan test, than those who did not have neuropathy. Researchers said the test may be useful for early diagnosis of diabetic neuropathy and for evaluation of responses to therapeutic interventions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC